Table 1 |
||||
|
Characteristics of the study patients according to type of ICU admission |
||||
|
Surgical patients (25) |
Medical patients (19) |
P value |
All (n = 44) |
|
|
|
||||
|
Age, years |
63 (57 to 68) |
63 (56 to 74) |
0.9 |
63 (56 to 71) |
|
Body mass index, kg/m2 |
26 (24 to 32) |
26 (24 to 30) |
0.8 |
26 (24 to 32) |
|
Male sex |
15 |
14 |
0.3 |
29 (66%) |
|
Chronic diseases |
||||
|
- Ischaemic heart disease |
2 |
7 |
9 (20%) |
|
|
- Arteriosclerosis obliterans |
2 |
2 |
4 (9%) |
|
|
- Diabetes |
5 |
5 |
10 (23%) |
|
|
- Chronic obstructive pulmonary disease |
1 |
4 |
5 (11%) |
|
|
- Asthma |
2 |
2 |
4 (9%) |
|
|
- Inflammatory disease (inflammatory bowel disease, vasculitis or rheumatoid diseases.) |
0 |
0 |
0 |
|
|
Focus of infection |
||||
|
-Lungs |
5 |
13 |
18 |
|
|
-Intra-abdominal |
14 |
2 |
16 |
|
|
-Urinary |
1 |
0 |
1 |
|
|
-Primary blood |
2 |
1 |
3 |
|
|
-Other |
3 |
3 |
6 |
|
|
Positive blood culture |
8 |
4 |
0.8 |
13 |
|
Hydrocortisone therapy |
19 |
13 |
0.6 |
32 (73%) |
|
Noradrenaline |
22 |
16 |
1.0 |
38 (86%) |
|
-maximum rate, μg/kg/minute |
0.44 (0.29 to 1) |
0.24(0.12 to 1.14) |
0.3 |
0.42(0.19 to 1) |
|
Adrenaline |
0 |
1 |
0.4 |
1 (2%) |
|
Vasopressin and analogues |
3 |
3 |
1.0 |
6 (14%) |
|
Activated protein C |
2 |
4 |
0.4 |
6 (14%) |
|
Length of stay at the intensive care unit |
7 (4 to 12) |
5 (4 to 12) |
0.7 |
7 (4 to 12) |
|
APACHE II |
24 (23 to 29) |
26 (22 to 30) |
0.7 |
26 (22 to 30) |
|
Organ failure |
18 |
12 |
0.5 |
30 (68%) |
|
SOFA |
8 (6 to 11) |
8 (7 to 11) |
0.9 |
8 (6 to 12) |
|
Lung spesific SOFA score even once three to four |
16 |
10 |
0.4 |
26 |
|
Mortality during the stay at the intensive care unit |
6 |
3 |
0.5 |
9 (21%) |
|
Mortality (30-days) |
7 |
4 |
0.6 |
11(25%) |
|
|
||||
|
Data is expressed as medians and 25th to 75th percentile or with frequencies and percentages. APACHE II = acute physiology and chronic health evaluation II; SOFA = sequential organ failure assessment. |
||||
|
Gäddnäs et al. Critical Care 2009 13:R53 doi:10.1186/cc7780 |
||||
